Bioactivities of a SiO2-CaO-ZrO2 glass in simulated body fluid and human parotid saliva

被引:5
作者
De Aza, PN
De Aza, S
机构
[1] Univ Miguel Hernandez, Inst Bioingn, Alicante 03202, Spain
[2] CSIC, Inst Ceram & Vidrio, Madrid, Spain
来源
BIOCERAMICS 16 | 2004年 / 254-2卷
关键词
bioactivity; human parotid saliva; simulated body fluid; in vitro; glass;
D O I
10.4028/www.scientific.net/KEM.254-256.75
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
A glass in the system wollastonite-zirconia, with a nominal composition of: 43.5 wt% SiO2 -43.5 wt% CaO -13wt% ZrO2. was obtained. This was soaked in two different solutions: simulated body fluid (SBF) and parotid human saliva (PHS), in order to compare its behaviour in a natural high protein content (PHS) medium and in an acellular protein-free solution (SBF). The SBF solution contained the same inorganic salts as in the human blood plasma, while the PHS contained both inorganic salts and various proteins. Both immersion systems were maintained for one month at 37degreesC. The results have shown that the glass does not show any in vitro bioactivity when is soaked in SBF. However, a hydroxyapatite-like (HA-like) layer is formed on its surface when immersed in PHS. The interfacial reactions product was examined by Scanning Electron Microscopy (SEM), fitted with Energy-Dispersive X-say Spectroscopy (EDS). Additionally, changes in ionic concentrations in both systems and pH right at the interface glass/surrounding fluid were also determined. The results confirm that to establish the potential bioactivity in vitro of a material, the physiological medium must be properly selected.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 15 条
[1]
Analytical control of wollastonite for biomedical applications by use of atomic absorption spectrometry and inductively coupled plasma atomic emission spectrometry [J].
De Aza, PN ;
Guitián, F ;
De Aza, S ;
Valle, FJ .
ANALYST, 1998, 123 (04) :681-685
[2]
Bioactivity of pseudowollastonite in human saliva [J].
De Aza, PN ;
Luklinska, ZB ;
Anseau, MR ;
Guitian, F ;
De Aza, S .
JOURNAL OF DENTISTRY, 1999, 27 (02) :107-113
[3]
DEAZA PN, 1993, J AM CERAM SOC, V76, P1052, DOI 10.1111/j.1151-2916.1993.tb05334.x
[4]
BIOACTIVITY OF WOLLASTONITE CERAMICS - IN-VITRO EVALUATION [J].
DEAZA, PN ;
GUITIAN, F ;
DEAZA, S .
SCRIPTA METALLURGICA ET MATERIALIA, 1994, 31 (08) :1001-1005
[5]
Morphological studies of pseudowollastonite for biomedical application [J].
DeAza, PN ;
Luklinska, ZB ;
Anseau, M ;
Guitian, F ;
DeAza, S .
JOURNAL OF MICROSCOPY, 1996, 182 :24-31
[6]
Bioceramics - Simulated body fluid interfaces: pH and its influence of hydroxyapatite formation [J].
DeAza, PN ;
Guitian, F ;
Merlos, A ;
LoraTamayo, E ;
DeAza, S .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1996, 7 (07) :399-402
[7]
DEAZA PN, 2003, BOL SOC ESP CERAM V, V42, P89
[8]
Indirect cytotoxicity evaluation of pseudowollastonite [J].
Dufrane, D ;
Delloye, C ;
Mckay, IJ ;
De Aza, PN ;
De Aza, S ;
Schneider, YJ ;
Anseau, M .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2003, 14 (01) :33-38
[9]
Gamble JL., 1967, CHEM ANATOMY PHYSL P
[10]
BIOCERAMICS - FROM CONCEPT TO CLINIC [J].
HENCH, LL .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1991, 74 (07) :1487-1510